
Karl I. Tamai
Supervisory Patent Examiner (ID: 10440, Phone: (571)272-2036 , Office: P/2800 )
| Most Active Art Unit | 2834 |
| Art Unit(s) | 2800, 2102, 2834 |
| Total Applications | 1170 |
| Issued Applications | 751 |
| Pending Applications | 67 |
| Abandoned Applications | 352 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18116292
[patent_doc_number] => 11547664
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-10
[patent_title] => Compositions and methods for treating eosinophilic disorders
[patent_app_type] => utility
[patent_app_number] => 16/894784
[patent_app_country] => US
[patent_app_date] => 2020-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 30
[patent_no_of_words] => 16114
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16894784
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/894784 | Compositions and methods for treating eosinophilic disorders | Jun 5, 2020 | Issued |
Array
(
[id] => 16589480
[patent_doc_number] => 10898724
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-26
[patent_title] => Wearable phototherapy apparatus with anti-viral and other effects
[patent_app_type] => utility
[patent_app_number] => 16/889799
[patent_app_country] => US
[patent_app_date] => 2020-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 20
[patent_no_of_words] => 20682
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 266
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16889799
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/889799 | Wearable phototherapy apparatus with anti-viral and other effects | May 31, 2020 | Issued |
Array
(
[id] => 16891991
[patent_doc_number] => 11033517
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Materials and methods for controlling infections
[patent_app_type] => utility
[patent_app_number] => 16/888678
[patent_app_country] => US
[patent_app_date] => 2020-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7188
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16888678
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/888678 | Materials and methods for controlling infections | May 29, 2020 | Issued |
Array
(
[id] => 18034490
[patent_doc_number] => 20220378705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => METHOD FOR PREPARING PHARMACEUTICAL COMPOSITIONS CONTAINING AMPHIPHILIC ACTIVE INGREDIENTS
[patent_app_type] => utility
[patent_app_number] => 17/614076
[patent_app_country] => US
[patent_app_date] => 2020-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4398
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614076
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/614076 | METHOD FOR PREPARING PHARMACEUTICAL COMPOSITIONS CONTAINING AMPHIPHILIC ACTIVE INGREDIENTS | May 22, 2020 | Pending |
Array
(
[id] => 17118670
[patent_doc_number] => 11129778
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-28
[patent_title] => Compositions containing microcapsules coated with deposition proteins
[patent_app_type] => utility
[patent_app_number] => 16/881820
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21157
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16881820
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/881820 | Compositions containing microcapsules coated with deposition proteins | May 21, 2020 | Issued |
Array
(
[id] => 20200407
[patent_doc_number] => 12403172
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-02
[patent_title] => Composition for preventing, alleviating or treating metabolic syndrome accompanied by obesity and/or diabetes, containing, as active ingredient, complex (IB complex) of Indian gooseberry extract and sprout barley extract
[patent_app_type] => utility
[patent_app_number] => 17/614749
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 5528
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614749
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/614749 | Composition for preventing, alleviating or treating metabolic syndrome accompanied by obesity and/or diabetes, containing, as active ingredient, complex (IB complex) of Indian gooseberry extract and sprout barley extract | May 18, 2020 | Issued |
Array
(
[id] => 16718542
[patent_doc_number] => 20210085689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT
[patent_app_type] => utility
[patent_app_number] => 16/868355
[patent_app_country] => US
[patent_app_date] => 2020-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16868355
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/868355 | PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT | May 5, 2020 | Abandoned |
Array
(
[id] => 16236647
[patent_doc_number] => 20200253881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/864323
[patent_app_country] => US
[patent_app_date] => 2020-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16864323
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/864323 | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof | Apr 30, 2020 | Issued |
Array
(
[id] => 17702678
[patent_doc_number] => 20220202684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => ADENOSINE PHOSPHATE-CONTAINING O/W TYPE EMULSION COMPOSITION HAVING LOW VISCOSITY
[patent_app_type] => utility
[patent_app_number] => 17/606252
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17606252
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/606252 | Adenosine phosphate-containing O/W type emulsion composition having low viscosity | Apr 23, 2020 | Issued |
Array
(
[id] => 17685832
[patent_doc_number] => 20220193124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => Therapeutic Agent for Flavivirus Infection
[patent_app_type] => utility
[patent_app_number] => 17/606413
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17606413
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/606413 | Therapeutic Agent for Flavivirus Infection | Apr 23, 2020 | Abandoned |
Array
(
[id] => 16359212
[patent_doc_number] => 20200315963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => Hydrocortisone Acetate Suppository Formulation For Treatment Of Disease
[patent_app_type] => utility
[patent_app_number] => 16/856806
[patent_app_country] => US
[patent_app_date] => 2020-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16856806
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/856806 | Hydrocortisone acetate suppository formulation for treatment of disease | Apr 22, 2020 | Issued |
Array
(
[id] => 16221149
[patent_doc_number] => 20200246265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => LIPOSOMES COMPRISING POLYMER-CONJUGATED LIPIDS AND RELATED USES
[patent_app_type] => utility
[patent_app_number] => 16/853635
[patent_app_country] => US
[patent_app_date] => 2020-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19341
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16853635
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/853635 | LIPOSOMES COMPRISING POLYMER-CONJUGATED LIPIDS AND RELATED USES | Apr 19, 2020 | Abandoned |
Array
(
[id] => 17741452
[patent_doc_number] => 11389497
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Pharmaceutical composition for treating cancer
[patent_app_type] => utility
[patent_app_number] => 16/850190
[patent_app_country] => US
[patent_app_date] => 2020-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 5280
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16850190
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/850190 | Pharmaceutical composition for treating cancer | Apr 15, 2020 | Issued |
Array
(
[id] => 17059035
[patent_doc_number] => 11103617
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-08-31
[patent_title] => Homogenous microporous hollow nano cellulose fibril reinforced PLA/PBS scaffolds for tissue engineering
[patent_app_type] => utility
[patent_app_number] => 16/848435
[patent_app_country] => US
[patent_app_date] => 2020-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 49
[patent_no_of_words] => 9883
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16848435
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/848435 | Homogenous microporous hollow nano cellulose fibril reinforced PLA/PBS scaffolds for tissue engineering | Apr 13, 2020 | Issued |
Array
(
[id] => 16375033
[patent_doc_number] => 20200323875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => MODIFIED RELEASE PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF MENTAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/845695
[patent_app_country] => US
[patent_app_date] => 2020-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16845695
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/845695 | Modified release pharmaceutical composition and method for the treatment of mental disorders | Apr 9, 2020 | Issued |
Array
(
[id] => 16898792
[patent_doc_number] => 20210177708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => SOLID MASK AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/843885
[patent_app_country] => US
[patent_app_date] => 2020-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6691
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16843885
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/843885 | Solid mask and preparation method therefor | Apr 8, 2020 | Issued |
Array
(
[id] => 17702661
[patent_doc_number] => 20220202667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => COSMETIC COMPRISING ULTRAVIOLET WAVELENGTH CONVERSION SUBSTANCE
[patent_app_type] => utility
[patent_app_number] => 17/601704
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11231
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601704
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/601704 | Cosmetic comprising ultraviolet wavelength conversion substance | Apr 2, 2020 | Issued |
Array
(
[id] => 16175129
[patent_doc_number] => 20200222097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => METHODS, DEVICES, AND SYSTEMS FOR BLOOD FLOW
[patent_app_type] => utility
[patent_app_number] => 16/837533
[patent_app_country] => US
[patent_app_date] => 2020-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16837533
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/837533 | Methods, devices, and systems for blood flow | Mar 31, 2020 | Issued |
Array
(
[id] => 17733118
[patent_doc_number] => 20220218577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => COSMETIC COMPOSITION FOR BLOCKING ULTRAVIOLET AND INFRARED RAYS
[patent_app_type] => utility
[patent_app_number] => 17/614102
[patent_app_country] => US
[patent_app_date] => 2020-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3880
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614102
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/614102 | Cosmetic composition for blocking ultraviolet and infrared rays | Mar 30, 2020 | Issued |
Array
(
[id] => 20534381
[patent_doc_number] => 12551431
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-17
[patent_title] => Peel-off film-forming cosmetic composition
[patent_app_type] => utility
[patent_app_number] => 17/599715
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7344
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17599715
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/599715 | Peel-off film-forming cosmetic composition | Mar 26, 2020 | Issued |